Zhiping Wu
Key Laboratory Of Digestive Diseases Of Gansu Province
Lanzhou, China
Lanzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: FEZF1-AS1 drives autophagy-mediated progression of colon cancer and reduces chemosensitivity through inhabiting the PI3K/AKT/mTOR signaling pathway.
Journal: Frontiers in genetics
Published: August 12, 2025
FEZF1-AS1 drives autophagy-mediated progression of colon cancer and reduces chemosensitivity through inhabiting the PI3K/AKT/mTOR signaling pathway.
Journal: Frontiers in genetics
Published: October 20, 2024
ULBP2 is a biomarker related to prognosis and immunity in colon cancer.
Journal: Molecular and cellular biochemistry
Published: August 24, 2022
Constructed the ceRNA network and predicted a FEZF1-AS1/miR-92b-3p/ZIC5 axis in colon cancer.
Journal: Molecular and cellular biochemistry
Published: July 16, 2022
NOX4 has the potential to be a biomarker associated with colon cancer ferroptosis and immune infiltration based on bioinformatics analysis.
Journal: Frontiers in oncology
Published: June 13, 2022
The high-dose amoxicillin-proton pump inhibitor dual therapy in eradication of Helicobacter pylori infection.
Journal: Expert review of gastroenterology & hepatology
Published: September 22, 2020
DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: December 31, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026